Zobrazeno 81 - 90
of 217
pro vyhledávání: '"Alessandro M. Gianni"'
Autor:
Giovanni Barosi, Mario Petrini, Alessandro M. Gianni, Pier Luigi Zinzani, Stefano Fanti, Umberto Vitolo, Sante Tura, Maurizio Martelli
Publikováno v:
American journal of hematology. 85(2)
90-yttrium-ibritumomab-tiuxetan is approved for treatment of rituximab-relapsed/refractory CD20+ follicular B-cell lymphoma and as consolidation therapy in untreated follicular lymphoma. Recommendations on the use of 90-yttrium-ibritumomab tiuxetan w
Autor:
Massimo Di Nicola, Carmelo Carlo-Stella, Alessandro M. Gianni, Cristiana Lavazza, Michele Magni, Arianna Giacomini, Franca Formelli, Daniela Sia, Antonino Carbone, Maura Francolini, Paolo Longoni, Loredana Cleris, Marco Milanesi, Marco Righi, Annunziata Gloghini
Publikováno v:
Blood. 115(11)
Adenovirus-transduced CD34+ cells expressing membrane-bound tumor necrosis factor–related apoptosis-inducing ligand (CD34-TRAIL+ cells) exert potent antitumor activity. To further investigate the mechanism(s) of action of CD34-TRAIL+ cells, we anal
Autor:
Carmelo Carlo-Stella, Liliana Devizzi, Daniela Sia, Arianna Giacomini, Anna Guidetti, Massimo Di Nicola, Roberto Passera, Paola Matteucci, Luigi Mariani, Michele Magni, Alessandro M. Gianni, Corrado Tarella, Rosalba Miceli, Stefano Buttiglieri, Marco Ruella, Silvia L. Locatelli, Alessandra Risso
Abstract 1289 Introduction: Myeloablative doses of Yttrium-90 (90Y)-Ibritumomab Tiuxetan combined with tandem autologous peripheral blood stem cell (PBSC) support can be safely administered to patients aged up to 76 years (Devizzi L et al, J Clin Onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e0441a918d58ca3140609feee5fd7ba
http://hdl.handle.net/11379/532272
http://hdl.handle.net/11379/532272
Autor:
M Di Nicola, Salvatore Siena, Gianni Bonadonna, Michele Magni, M. Bregni, Alessandro M. Gianni
Publikováno v:
Scopus-Elsevier
Hematopoietic progenitor cells circulate in the peripheral blood (PB) of cancer patients during the recovery phase that follows treatment with high-dose cyclophosphamide followed by hematopoietic growth factor infusion. We report that when PB progeni
Publikováno v:
The oncologist. 14
High-dose chemotherapy (HDC) conditioning given in association with autologous stem cell transplantation (ASCT) or reduced-intensity conditioning (RIC) with allogeneic stem cell transplantation (alloSCT) are established treatment approaches for patie
Autor:
Annalisa Chiarenza, Giovanni Pizzolo, Ignazio Majolino, Antonino Mulè, Angela Gueli, Tiziano Barbui, Guido Gini, Roberto Marchioli, Andrés J.M. Ferreri, Francesco Rodeghiero, Paolo Corradini, Pietro Leoni, Massimo Di Nicola, Sergio Cortelazzo, Alessandro Rambaldi, Giorgio La Nasa, Alessandro M. Gianni, Livio Trentin, Francesco Di Raimondo, Atto Billio, Marco Ladetto, Manuela Zanni, Corrado Tarella, Andrea Gallamini, Caterina Patti, Fabio Benedetti, Anna Maria Barbui
Abstract 1220 Poster Board I-242 Background The outcome of B-cell diffuse large B-cell lymphoma (DLB-CL) patients has definitely improved since the introduction of therapeutic programs combining chemotherapy and the anti CD20 rituximab. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb7be3ad7fd6a961296db6de4ab36c1a
http://hdl.handle.net/20.500.11769/82355
http://hdl.handle.net/20.500.11769/82355
Autor:
Carmelo Carlo-Stella, Marco Righi, Daniela Sia, Cristiana Lavazza, Arianna Giacomini, Alessandro M. Gianni
Experimental approaches currently used to quantify the activity of antiangiogenic treatments in cancer therapy do not generally address the importance of spatial distribution of microvessels in target tissues. We report a new computerized method to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab773bb66e899fba2c2be0ef0d04641
http://hdl.handle.net/11379/502241
http://hdl.handle.net/11379/502241
Autor:
Paola Baldassari, Roberta Mortarini, Carmelo Carlo-Stella, Michele Magni, Liliana Devizzi, Roberta Zappasodi, Alessandro M. Gianni, Massimo Di Nicola, Paola Matteucci, Andrea Anichini, Fernando Ravagnani, Antonello Cabras, Serenella M. Pupa
Publikováno v:
Blood. 113(1)
Eighteen relapsed patients with measurable indolent non-Hodgkin lymphoma (NHL) were vaccinated with dendritic cells (DCs) loaded with killed autologous tumor cells. Six patients had objective clinical responses including 3 continuous complete respons
Publikováno v:
Advances in experimental medicine and biology. 610
Autor:
S. Mirto, Alessandro Pileri, Tiziano Barbui, Mario Boccadoro, Ignazio Majolino, Paolo Corradini, Alessandro M. Gianni, Sergio Cortelazzo, Giovanni Pizzolo, Andrea Gallamini, Roberto Passera, Fabio Benedetti, Fabio Ciceri, Caterina Patti, Corrado Tarella, Manuela Zanni, Michele Magni, Alessandro Rambaldi
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(19)
Purpose To investigate the impact of adding rituximab to intensive chemotherapy with peripheral-blood progenitor cell (PBPC) autograft for high-risk diffuse large B-cell lymphoma (DLB-CL) and follicular lymphoma (FL). Patients and Methods Data were c